Adam Esham, MD
Urology · Chillicothe, OHNPI 1801090469
Payments from drug & device makers
Across 25 payments — averaging $28.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rochester Medical Corporation$255
- Boston Scientific$166
- Johnson & Johnson$78
- C. R. Bard, Inc. & Subsidiaries$71
- KARL Storz Endoscopy-america$40
- Ambu Inc.$25
- plus $66 from 4 others
What the payments were for
- Food & beverage$701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rochester Medical Corporation | 7 | $255 |
| Boston Scientific | 6 | $166 |
| Johnson & Johnson | 3 | $78 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $71 |
| KARL Storz Endoscopy-america | 1 | $40 |
| Ambu Inc. | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $24 |
| Tolmar, Inc. | 1 | $15 |
| Tolmar Pharmaceuticals, Inc. | 1 | $14 |
| Teleflex LLC | 1 | $13 |
How this compares
$701 in reported general payments places this provider in the 25th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 22 | $17,130 |
| Tamsulosin Hcl | 331 | $5,074 |
| Estradiol | 64 | $3,152 |
| Testosterone Cypionate | 78 | $2,143 |
| Potassium Citrate ErPotassium Citrate | 15 | $1,426 |
| Finasteride | 128 | $1,230 |
| Tolterodine Tartrate | 13 | $1,097 |
| Oxybutynin Chloride | 38 | $1,089 |
| Oxybutynin Chloride ErOxybutynin Chloride | 46 | $740 |
| Solifenacin Succinate | 16 | $681 |
| Cephalexin | 79 | $586 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $314 |
| Betamethasone Valerate | 17 | $184 |
| Tramadol Hcl | 103 | $117 |
| Hyoscyamine Sulfate | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Other urology in Chillicothe
- Marc PliskinCincinnati$20.8M
- Lawrence GervasiMiddleburg Heights$4.7M
- Martin FritzhandCincinnati$4.6M
- Kamal PoharCincinnati$3.4M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.